Life Sciences Strategy Summit on IP & Exclusivity returns to Munich in October, carrying IPKat readers’ discount
 |
| Networking at "Katzentempel" |
400+ leading life science legal specialists, with a 50% in-house counsel ratio, will gather to gain a comprehensive, cross-disciplinary understanding of the exclusivity landscape in Europe.
This year’s agenda includes the following topics:
- SPC and PTE protection across key jurisdictions, with a focus on the strategic insights needed to extend product lifecycle.
- Patent strategy challenges, alongside essential regulatory developments impacting product development and approval.
- The evolving litigation environment, including the latest trends in competition law affecting both originator and generic companies.
Also key to the 2025 edition are the following aspects:
- Three days of expert-led sessions on the UPC, divisional patents, clinical trial regs, and more – all focused on commercially critical legal issues.
- 15+ hours of networking, 1:1 meetings, roundtables, and receptions – all via the conference’s easy-to-use event app.
- Meeting top legal decision-makers from major originator, biotech, biosimilar, and generic companies worldwide.
The full agenda is available here.
IPKat readers are entitled to a 15% discount in the registration fee using VIP code IPKATSM15 at checkout. For further information and to register, click here.
Life Sciences Strategy Summit on IP & Exclusivity returns to Munich in October, carrying IPKat readers’ discount
Reviewed by Eleonora Rosati
on
Tuesday, June 10, 2025
Rating:
Reviewed by Eleonora Rosati
on
Tuesday, June 10, 2025
Rating:
Follow the IPKat on LinkedIn 
![[UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva?](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiq8nBoNt-e3wprqLLKpCrLrwgq-jlUJjQkoVYKzUR7ppQ2ssWrPpA6uQunU49Y3s216DkeyQHN2bw0C2cDUlnwYWlQZIn7fi9vynFF5rS0JxrDx4qHKB82RM5P45wh5JHkI-f0I9sGFuQ4OVkPIIfvjec1UtVj-UyEvcBM-ApvTjK39-QxbXEz6w/s72-c/A%20whimsical%20cat-themed%20jigsaw%20puzzle%20partially%20assembled%20on%20a%20wooden%20table,%20with%20the%20cityscape%20of%20Li.jpeg)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html